Dosimetry for therapeutic treatment of neuroblastoma by 131I-mIBG

被引：0
|
作者：
Sudbrock, F.
Eschner, W.
Schmidt, M.
Simon, T.
Hero, B.
Schicha, H.
机构：
[1] Univ Cologne, Nukl Med Klin & Poliklin, D-50937 Cologne, Germany
[2] Univ Cologne, Zentrum Kinderonkol & Hamatol, D-50937 Cologne, Germany
来源：
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2006年 / 45卷 / 06期
关键词：
neuroblastom; mIBG-Therapie; ganzkorperszintigraphie; SPECT dosimetrie; energiedosis;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Aim: Targeted radiotherapies using iodine-131 meta-iodobenzylguanidin have long been in use for treatment of stage IV neuroblastoma but reliable dosimetric data are scarce. Method: This work presents an approach to determine the whole body exposure and tumour doses delivered during therapy. Dosimetric data are reported and discussed for six treatments carried out according to the trial protocol NB2004 as it is in use in our study in the last two years. Results: Whole body exposures are found to be in the range of 1.75 to 2.5 Gy whereas tumour doses vary between 15 and 55 Gy. Conclusion: The course of action prescribed by the trial protocol allows whole body exposure as well as tumour doses to be determined routinely.
引用
收藏
页码：254 / 261
页数：8
相关论文
共 50 条
  • [1] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Simon, Thorsten
    Eschner, Wolfgang
    Berthold, Frank
    Schicha, Harald
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1279 - 1290
  • [2] Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma
    Ferdinand Sudbrock
    Matthias Schmidt
    Thorsten Simon
    Wolfgang Eschner
    Frank Berthold
    Harald Schicha
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1279 - 1290
  • [3] Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours
    Monsieurs, MA
    Thierens, HM
    Vral, A
    Brans, B
    De Ridder, L
    Dierckx, RA
    NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (04) : 367 - 374
  • [4] Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma
    Buckley, Susan E.
    Chittenden, Sarah J.
    Saran, Frank H.
    Meller, Simon T.
    Flux, Glenn D.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (09) : 1518 - 1524
  • [5] The Role of 131I-MIBG in High-Risk Neuroblastoma Treatment
    Lessig, Megan Kinnear
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2009, 26 (04) : 208 - 216
  • [6] Biomarker Modulations in Children With Neuroblastoma Following Treatment With 131I-mIBG
    Imber, B. S.
    Olow, A.
    Karski, E. E.
    Allen, I. E.
    DuBois, S. G.
    Haas-Kogan, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S729 - S730
  • [7] Dosimetry for Repeated 131I-mIBG Therapy of Phaeochromoblastoma
    Happel, C.
    Selkinski, I.
    Middendorp, M.
    Sauter, B.
    Plastowez, W.
    Diener, J.
    Kranert, W. T.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S417 - S417
  • [8] Tumor dosimetry of 131I-MIBG in animal models of neuroblastoma using 124I-MIBG and microPET/CT
    Seo, Youngho
    Gustafson, W.
    Dannoon, Shorouk
    Lee, Chang-Lae
    Taylor, Stephanie
    VanBrocklin, Henry
    Hernandez-Pampaloni, Miguel
    Haas-Kogan, Daphne
    Weiss, William
    Matthay, Katherine
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [9] Iodine-131 metaiodobenzylguanidine (131I-mIBG) treatment in relapsed/refractory neuroblastoma
    Anongpornjossakul, Yoch
    Sriwatcharin, Wattanun
    Thamnirat, Kanungnij
    Chamroonrat, Wichana
    Kositwattanarerk, Arpakorn
    Utamakul, Chirawat
    Sritara, Chanika
    Chokesuwattanasakul, Payap
    Thokanit, Nintita Sripaiboonkij
    Pakakasama, Samart
    Anurathapan, Usanarat
    Pongphitcha, Pongpak
    Chotipanich, Chanisa
    Hongeng, Suradej
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (04) : 336 - 343
  • [10] High dose dosimetry-guided 131I-MIBG treatment for refractory primary neuroblastoma: a case report
    Boni, G.
    Borso, E.
    Mazzarri, S.
    Menconi, M.
    Casazza, G.
    Favre, C.
    Traino, C. A.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S532 - S532
12345